Order Article Reprints

Ellis PM, Morzycki W, Melosky B, Butts C, Hirsh V, Krasnoshtein F, Murray N, Shepherd FA, Soulieres D, Tsao MS, et al. The Role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic, and Recurrent Non-Small-Cell Lung Cancer: A Canadian National Consensus Statement. Current Oncology. 2009; 16(1):27-48. https://doi.org/10.3747/co.v16i1.393

Ellis, Peter M., W. Morzycki, B. Melosky, C. Butts, V. Hirsh, F. Krasnoshtein, N. Murray, F. A. Shepherd, D. Soulieres, M. S. Tsao, and et al. 2009. "The Role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic, and Recurrent Non-Small-Cell Lung Cancer: A Canadian National Consensus Statement" Current Oncology 16, no. 1: 27-48. https://doi.org/10.3747/co.v16i1.393

Ellis, P. M., Morzycki, W., Melosky, B., Butts, C., Hirsh, V., Krasnoshtein, F., Murray, N., Shepherd, F. A., Soulieres, D., Tsao, M. S., & Goss, G. (2009). The Role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic, and Recurrent Non-Small-Cell Lung Cancer: A Canadian National Consensus Statement. Current Oncology, 16(1), 27-48. https://doi.org/10.3747/co.v16i1.393